Sfoglia per Rivista  HEART FAILURE REVIEWS

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 16 di 16
Titolo Data di pubblicazione Autore(i) File
Acute and chronic endothelial dysfunction: implications for the development of heart failure. 1-gen-2003 A., Linke; Recchia, FABIO ANASTASIO; X., Zhang; T. H., Hintze
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 1-gen-2022 Morfino, P.; Aimo, A.; Panichella, G.; Rapezzi, C.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure 1-gen-2021 Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.
Cardiogenic shock and acute kidney injury: the rule rather than the exception 1-gen-2020 Ghionzoli, N.; Sciaccaluga, C.; Mandoli, G.; Vergaro, G.; Gentile, F.; D'Ascenzi, F.; Mondillo, S.; Emdin, M.; Valente, S.; Cameli, M.
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 1-gen-2020 Barison, A.; Aimo, A.; Todiere, G.; Grigoratos, C.; Aquaro, G. D.; Emdin, M.
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 1-gen-2010 Lionetti, Vincenzo; Bianchi, Giacomo; Recchia, FABIO ANASTASIO; Ventura, Carlo
COVID-19 and myocarditis: a systematic review and overview of current challenges 1-gen-2021 Castiello, T.; Georgiopoulos, G.; Finocchiaro, G.; Claudia, M.; Gianatti, A.; Delialis, D.; Aimo, A.; Prasad, S.
Current and emerging drug targets in heart failure treatment 1-gen-2021 Ghionzoli, N.; Gentile, F.; Del Franco, A. M.; Castiglione, V.; Aimo, A.; Giannoni, A.; Burchielli, S.; Cameli, M.; Emdin, M.; Vergaro, G.
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets 1-gen-2021 Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M.
The paradox of low BNP levels in obesity 1-gen-2012 Clerico, Aldo; Giannoni, A.; Vittorini, S.; Emdin, Michele
Pirfenidone as a novel cardiac protective treatment 1-gen-2021 Aimo, A.; Spitaleri, G.; Panichella, G.; Lupon, J.; Emdin, M.; Bayes-Genis, A.
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 1-gen-2021 Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.
Postmortem cardiac magnetic resonance in sudden cardiac death 1-gen-2018 Guidi, B.; Aquaro, G. D.; Gesi, M.; Emdin, M.; Di Paolo, M.
The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev 2014; 19:727-42. 1-gen-2014 M., Cantinotti; Y., Law; S., Vittorini; M., Crocetti; M., Marco; B., Murzi; Clerico, Aldo
Role of nitric oxide in the regulation of substrate metabolism in heart failure 1-gen-2002 Recchia, FABIO ANASTASIO
Subclinical cardiac damage in cancer patients before chemotherapy 1-gen-2021 Fabiani, I.; Panichella, G.; Aimo, A.; Grigoratos, C.; Vergaro, G.; Pugliese, N. R.; Taddei, S.; Cardinale, D. M.; Passino, C.; Emdin, M.; Giannoni, A.
Mostrati risultati da 1 a 16 di 16
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile